Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting. Read more about Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.
Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort. Read more about Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort.
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. Read more about Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.
Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Read more about Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer.
Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Read more about Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category.
Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Read more about Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. Read more about Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting. Read more about Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy. Read more about Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy.
Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study. Read more about Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.
